DISCLAIMERThe information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.
|rareLife solutions 606 Post Road East #397
Westport, CT 06880
|You are receiving this because you have an account on www.oneAMYLOIDOSISvoice.com|
|To unsubscribe from these emails, click here|
Trusted Resources: News & Meetings
Latest announcements and gatherings
Alexion Pharmaceuticals (ALXN) has been one of the greatest growth stories in the ultra-rare disease space over the past decade, with their blockbuster C5 inhibitor, Soliris, growing sales to nearly $4 billion in 2018. Although the company still managed to grow top-line revenue by more than 19% in 2018 (without any price increases), market share in their lead indications of PNH and aHUS is becoming somewhat saturated, and they are looking for new growth avenues.
In an effort to continue executing on this goal, on January 31st, Alexion Pharmaceuticals entered into a partnership with Caelum Biosciences (a Fortress Biotech (FBIO) company) to co-develop their lead asset for the treatment of Light-Chain Amyloidosis. This is Alexion’s first endeavor in treating amyloidosis, and I believe the partnership could be one of their most lucrative to date.
people & placesBarnes-Jewish Hospital, Washington University Amyloid CenterAt the Washington University Amyloid Cen...
educationAL Amyloidosis and the KidneyIn AL amyloidosis, an abnormal protein c...
news & meetingsMayo Clinic Patient Symposium in Plasma Cell Disorders 2021: Patient and Family RegistrationMayo Clinic School of Continuous Profess...
videos & visualsISA 2020 | Auto-HSCT in AL Amyloidosishttps://www.youtube.com/watch?time_conti...
people & placesThe Princess Alexandra Hospital Amyloidosis CentreThe Princess Alexandra Hospital (PAH) Am...
videos & visualsWebinar Presentation by Johnathan Wall on Imaging Systemic Amyloidosis (AL)https://www.youtube.com/watch?v=RHfV9jW-...
videos & visualsMessage to Physicians From Cardiac Amyloidosis Patienthttps://www.youtube.com/watch?v=C2xv62cI...
send a message
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.